UBS Call 460 MUV2 20.09.2024/ CH1329491059 /
10/06/2024 19:25:43 | Chg.-0.160 | Bid21:50:11 | Demandez à21:50:11 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
2.260EUR | -6.61% | - Bid taille: - |
- Ask la taille: - |
MUENCH.RUECKVERS.VNA... | 460.00 - | 20/09/2024 | Call |
GlobeNewswire
06:00
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Newsfile Corp
05:22
"Winds of Change" Celebrating Kazakhstan's National Parks at The Canvas 3.0 Exhibition June 8th - Ju...
GlobeNewswire
05:16
Northwest China's Yangling setting benchmark for SCO agriculture technology cooperation for shared g...
GlobeNewswire
04:50
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover...
GlobeNewswire
04:19
President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday
GlobeNewswire
03:00
AUTODESK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been F...
GlobeNewswire
03:00
MARINUS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fi...
GlobeNewswire
02:00
ROSEN, LEADING INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before ...
GlobeNewswire
02:00
ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...
GlobeNewswire
01:19
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page